The Medicines and Healthcare Products Regulatory Authority (MHRA) has announced a recall over Xarelto 20mg film-coated tablets made by Strathclyde Pharmaceuticals Ltd. Better known as Rivaroxaban, the tablets are packaged into blister strips with the weight labelled on one side.
A batch is reportedly affected by the recall following reports of rogue blister strips carrying 15mg tablets finding their way into the twin pack 20mg tablets.
The batch number in question is BXHHDR1, due to expire in September 2019. The 28-tablet packets were reportedly first distributed on 18th September 2017.
Continue Reading…

We’ve already acknowledged a reported over-reliance on prescription medication here in the U.K., with fears of an “opioid epidemic” in America creeping across the pond to our shores as well. Unless, it’s already here…
In what’s being described as an “epidemic” and a “crisis” in the U.S., opioids are apparently being used way too much, leading to serious and needless addictions whilst reportedly lining the pockets of the super-rich pharmaceutical corporations.
We look at this growing problem and comment on why we ought to be concerned.
Continue Reading…